Skip to Main Content
Skip Nav Destination

Navigating Pediatric CVAD Care: Choosing Effective Lock Solutions

February 3, 2024

Editor’s Note: Dr. Alex Eaton (he/him) is a first-year resident physician in pediatrics at The Boston Combined Residency Program at Boston Children's Hospital and Boston Medical Center. He is interested in medical education and health disparities research, specifically the intersection of pediatric pain control and historic practices of race-based medicine. Alex is planning to pursue a fellowship specializing in pediatric critical care. - Rachel Y. Moon, MD, Associate Editor, Digital Media, Pediatrics

Children with complex medical treatments that require central venous access devices (CVADs) face heightened risks of infections and blood clots. One way to prevent these complications is to put a solution in the CVAD tubing that will provide a fluid “lock” to keep blood from collecting in the tubing. There are many catheter lock solutions, including those containing heparinized saline, chelating agents, antibiotics, preventative thrombolytics, and ethanol. A comprehensive meta-analysis of 29 trials spanning 32 years and involving 2970 children that illuminates the complex decision-making involved in choosing a catheter lock solution early released in Pediatrics. This study, entitled “Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis by Mari Takashima and colleagues at the University of Queensland and St Jude Children's Research Hospital, seeks to come to a consensus on what works best (10.1542/peds.2023-063264).

Unlocking the Choices: A Balancing Act

Preventing and treating CVAD-associated complications requires a delicate balance. Ideally, you want a lock solution that will minimize the risk of both infection and occlusion from blood clots. This meta-analysis revealed that:

  • For preventing CVAD-associated bloodstream infections, chelating and antibiotic locks are better than heparinized saline solutions.
  • For preventing CVAD occlusion from blood clots, thrombolytic agents are better than heparinized saline solutions. Ethanol increases the odds of CVAD occlusion, possibly due to its interaction with biofilm or plasma proteins.

Choosing the Right Lock Solution: A Complex Decision

Current standards recommend heparin or preservative-free sodium chloride for CVAD locking. Antimicrobial locking solutions like ethanol, taurolidine, citrate, and others are recommended for long-term CVADs, high-risk patients, or facilities with high rates of central line-associated bloodstream infections. However, rising rates of antibiotic resistance emphasize the need for exploring non-antimicrobial alternatives.

Treatment Dilemma: The Need for More Research

None of the lock solutions exhibited consistent superiority across the various medical complications one might encounter with the use of CVADs, emphasizing the great need for further research with larger sample sizes. Clear outcome reporting that distinguishes short-term treatment failure from long-term outcomes, including relapse and re-infection, will be important.

Conclusion: Illuminating Pediatric CVAD Care

This meta-analysis provides compelling evidence supporting the effectiveness of chelating and antibiotic locks in preventing CVAD-associated bloodstream infection in pediatric patients compared to heparinized locks alone. Thrombolytic agents show promise for preventing occlusion, while caution is advised in the use of ethanol locks alone. Further research is imperative to validate these findings and assess the efficacy of various lock solutions for diverse catheter-related complications in pediatric patients.

Close Modal

or Create an Account

Close Modal
Close Modal